Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes. A post hoc analysis from the REWIND randomized trial
Aim To assess the occurrence of atrial fibrillation or atrial flutter (atrial arrhythmias [AA]) in patients with type 2 diabetes treated with once-weekly subcutaneous dulaglutide versus placebo. Materials and Methods Patients without electrocardiographic (ECG)-confirmed AA at baseline and rando...
Saved in:
Institution: | Universidad EIA |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Artículo de revista |
Language: | English |
Published: |
Diabetes, Obesity and Metabolism
2022-01-04
|
Online Access: | https://repositorio.udes.edu.co/handle/001/6086 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|